Recruiting
Pyrexia+1
RecruitingStudy on the Safety and Immune Response of the 20-Valent Pneumococcal Vaccine in Adults with Fever and High Risk for Pneumococcal Infection
Registered drugNo placebo
Study on the Safety and Immune Response of the 20-Valent Pneumococcal Vaccine in Adults with Fever and High Risk for Pneumococcal Infection
Registered drugNo placebo
- Disease:PyrexiaImmunisation
- Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium PhosphatePneumococcal polysaccharide serotype 10A conjugated to CRM197+35
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
- Sponsor:Centre Hospitalier Universitaire De Saint Etienne



